Atlas Trials

Pompe Disease (Infantile-Onset)

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pompe Disease (Infantile-Onset)

RecordFirmDate
Registry of Patients Diagnosed With Lysosomal Storage Diseases (NCT05619900)University of California, San Francisco2022-05-31
MSOT in Pompe Disease (NCT05083806)University of Erlangen-Nürnberg Medical School2022-05-17
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) (NCT04532047)University of California, San Francisco2021-07-01
Exercise Capacity in Response to Enzyme Replacement Therapy in Pediatric Pompe Disease. (NCT04755751)Rambam Health Care Campus2018-06-24
A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease (NCT01597596)Genzyme, a Sanofi Company2012-08-01
Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies (NCT00763932)Genzyme, a Sanofi Company2003-04-01
Expanded Access for ATB200/AT2221 for the Treatment of IOPD (NCT04327973)Amicus Therapeutics

Track Pompe Disease (Infantile-Onset) automatically

Every clearance here is in the API, with alerts when new ones post.